JLP:Jubilee Metals had a dreadful week, giving back half of last week's gains and dropping 37% of my purchase price. Hopefully that was just profit taking and we can get it back next week.
ASHM:Ashmore Group was a new share I bought after selling
PAF:Pan African Resources. My plan is to buy back into PAF when
my pension transfer arrives, but I wanted to get ASHM before the
dividend and there wouldn't have been time if I'd waited. It didn't turn out
too well as PAF continued upwards as the price of gold surged, whereas
ASHM lost 6% as it dropped nearly every day since I bought it.
TLOU:Tlou Energy also fell 6%. I don't know why this has gone so
low, as it's doing everything right on the ground. I think once construction
of the power lines starts then maybe sentiment will improve.
BLU:Blue Star Capital continues to yo-yo and this week climbed 6% and is only 38%
down.
Blackrock World Gold Fund also climbed 6% and has gone 3% into the
green. iShares Physical Gold has also move into profit, which is more
than I can say for most of my gold mines.
Share of the week is SBTX:SkinBioTherapeutics which for no apparent
reason climbed 25% and my holding went onto profit. Given
OPTI:Optibiotix own a large number of shares, it's frankly
unbelievable that they didn't rise a penny this week.
Looking pretty flat.
Still below the trend line
Here's the ISA and shares portfolio after week 29 of year 7.
Potential profits dropped by £285 thanks to JLP:Jubilee Metals, but it would have been more if SBTX:SkinBioTherapeutics hadn't gone £34 into profit. The drop in portfolio value was pretty negligible, but a hit to the morale as long-term performance dips beneath 10%.
The flattest few weeks for a long time
Running parallel to the trend line, but unfortunately still below it.
| Weekly Change | |||
| Cash | £29.55 |
+£0 | |
| Portfolio cost | £72,195.21 | +£0 | |
| Portfolio sell value (bid price-commission) | £45,904.90 | (-36.4%) | -£182.87 |
| Potential profits | £2,329.69 | -£285.60 | |
| Yr 7 Dividends | £22.16 | +£0 | |
| Yr 7 Profit from sales | £3,664.29 | +£0 | |
| Yr 7 projected avg monthly profit | £547.49 | (14.9%) | -£19.55 |
| Total Dividends | £1,365.31 | +£0 | |
| Total Profit from sales | £27,788.23 | +£0 | |
| Average monthly cash profit |
£366.61 |
(9.9%) | -£1.08 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Compound performance | 65% | +0% |
Potential profits dropped by £285 thanks to JLP:Jubilee Metals, but it would have been more if SBTX:SkinBioTherapeutics hadn't gone £34 into profit. The drop in portfolio value was pretty negligible, but a hit to the morale as long-term performance dips beneath 10%.
The flattest few weeks for a long time
Running parallel to the trend line, but unfortunately still below it.
The SIPP looks like this after week 325 overall and week 13 of year 7.
I sold my PAF:Pan African Resources shares because I foolishly believed the price of gold had spiked, but it carried on rising as did their share price. It doesn't really matter because I sold my shares at 19.3375p having paid 16.4936p to make £143.50 (14.5%) profit. My target for magic formula shares is 10% plus a dividend, and the £41 dividend from December takes the overall return to 18% in just a few months.
| Weekly Change | ||||
| Cash | £211.86 | +£144.72 | ||
| Portfolio cost | £81,533.18 | -£1.40 | ||
|
Portfolio sell value (bid price - commission) |
£52,002.18 | (-36.2%) | +£76.76 | |
| Potential profits | £148.30 | +£30.11 | ||
| Yr 7 Dividends | £81.54 | +£0 | ||
| Yr 7 Interest | £0 | +£0 | ||
| Yr 7 Profit from sales | £524.53 | +£143.49 | ||
| Yr 7 projected avg monthly profit | £185.18 | (4.4%) | +£36.32 | |
| Total Dividends | £3,285.93 | +£0 | ||
| Total Interest | £0.20 | +£0 | ||
| Total Profit from sales | £24,249.16 | +£143.49 | ||
| Average monthly cash profit | £355.50 | (8.5%) | +£0.82 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Compound performance | 53% | +0% |
I sold my PAF:Pan African Resources shares because I foolishly believed the price of gold had spiked, but it carried on rising as did their share price. It doesn't really matter because I sold my shares at 19.3375p having paid 16.4936p to make £143.50 (14.5%) profit. My target for magic formula shares is 10% plus a dividend, and the £41 dividend from December takes the overall return to 18% in just a few months.
I wanted to get back into ASHM:Ashmore Group before their dividend
ex-date on 3rd March. I bought 358 shares at 278.8977p costing £1,015.39
with commission and stamp duty. I actually sold my original holding for £104
loss because I had a panic over their exposure to Evergrande which looked
like they were going bust. Since then the price has dropped 70p so I think
that risk is priced in, and Evergrande got a bail-out and may continue to be
bailed out given the impact of them going bust. I think a P/E ratio of 7.5
gives this potential to double over the next 12 months if the Evergrande
issue blows over. It is a risk, and the combination of spread and further
drops mean these are already 6% down so it's not an auspicious start. I can
only hope there's some buying on the run up to dividend day.
The sale improved year 7 performance a bit, but barely had any impact on
long term performance at all, with just 82p added to my average monthly
profit.
Potential profits actually increased despite the sale. This was thanks to
SBTX:SkinBioTherapeutics going £128 into profit,
Blackrock World Gold going £3 into profit, and
iShares Physical Gold going £17 into profit.
Same as the other charts
Just on the trend line is better than below it.
Same as the other charts
Just on the trend line is better than below it.
The trading account looks like this after week 291 overall and week 31 of year 6.
An increase for the second week in a row, despite DDDD:4D Pharma falling further. This account is still doomed to be in the red for years though.
Will this last for more than 2 weeks?
| Weekly Change | |||
| Cash | £259.74 | +£0 | |
| Portfolio cost | £2,374.14 | +£0 | |
| Portfolio sell value (bid price - commission) | £814.55 | (-65.7%) | +£26.51 |
| Potential profits | £0.00 | +£0 | |
| Year 6 Dividends | £0.00 | +£0 | |
| Year 6 Profit | £0.00 | +£0 | |
| Yr 6 projected avg monthly profit | £0.00 | (0%) | +£0 |
| Dividends | £60.10 | +£0 | |
| Profit from sales | £937.88 | +£0 | |
| Average monthly cash profit | £14.86 | (7.5%) | -£0.05 |
|
(Sold stocks profit + Dividends - Fees / Months) |
An increase for the second week in a row, despite DDDD:4D Pharma falling further. This account is still doomed to be in the red for years though.
Will this last for more than 2 weeks?
Above the trend line for the first time in a while
I should be able to apply for my pension transfer next week. I think it will
be £2,100, and my plan is still to buy back into
PAF:Pan African Resources with £1,000, but only once they have dropped
back a bit. The rest of the balance will go on
CAML:Central Asia Metals which I wish I could get now while they're
cheaper than when I last sold them. If PAF doesn't drop back, then
there are other magic formula shares to look at.
APAX:Apax Global Alpha went on an amazing run after I sold them
for £324 profit, as did POLR:Polar Capital Holdings after I sold
for £565 profit, but both have dropped back to only a little above what I sold
them for, so I may go back to them. WHR:Warehouse REIT are now cheaper
than when I sold them and are next on the list. All pay great dividends and
sit near the top of my magic formula rankings. It will take a few weeks for
the transfer to come through so I'll watch all these closely.
No comments:
Post a Comment